Discover the importance of adult vaccination in India, the barriers faced, and the urgent need for prioritization.

Bradley Monk shares key insights and breakthroughs in gynaecologic oncology from ESGO 2025, shaping cancer care's future.

Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) had its price target lowered by Jefferies Financial Group from $70.00 to $53.00 in a research report report published on Tuesday,Benzinga reports.

Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and answers are republished by permission.

Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid.

Leveraging its World Health Organization (WHO)-prequalified Typhoid Conjugate Vaccine (ZyVac TCV) and a Shigella vaccine from ...

PDS Biotechnology has commenced the randomised, multi-centre Phase III clinical trial, VERSATILE-003, to assess the efficacy ...

Shares of Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) gapped down prior to trading on Monday after HC Wainwright lowered their price target on the stock from $11.00 to $10.00. The stock had ...

Once upon a time, the idea of a “sugar momma” was met with raised eyebrows, whispered speculation, or outright dismissal. But ...

BioNTech's malaria vaccine trial faces an FDA clinical hold. The company is addressing concerns and collaborating with ...

A dividend from immunisation is a future free from the diseases that rob communities of health and well-being, a future free ...

Frazier Life Sciences has launched Callio Therapeutics with $187 million in series A funds and a HER2-targeted dual-payload ...